erythromycin is a lipid of Polyketides (PK) class. Erythromycin is associated with abnormalities such as Systemic Inflammatory Response Syndrome, Pneumonia, Infection, Pneumococcal Infections and Exanthema. The involved functions are known as Pharmacodynamics, Sterility, Agent, Drug Kinetics and Adjudication. Erythromycin often locates in Blood, peritoneal, Extracellular, Ribosomes and apicoplast. The associated genes with erythromycin are P4HTM gene, SLC33A1 gene, FAM3B gene, Operon and Homologous Gene. The related lipids are Hydroxytestosterones, Steroids, Propionate, Mycolic Acids and campesterol. The related experimental models are Mouse Model and Knock-out.
To understand associated biological information of erythromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
erythromycin is suspected in Pneumonia, Infection, Gonorrhea, Cystic Fibrosis, Respiratory Tract Infections, Influenza and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with erythromycin
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
Mouse Model are used in the study 'In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis.' (Falzari K et al., 2005) and Mouse Model are used in the study 'Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.' (Cynamon MH et al., 2000).
Knock-out are used in the study 'Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening.' (McLaughlin LA et al., 2008).
Model | Cross reference | Weighted score | Related literatures |
---|
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Miller KE | Diagnosis and treatment of Chlamydia trachomatis infection. | 2006 | Am Fam Physician | pmid:16669564 |
Raz R and Bitnun S | Dilemmas of streptococcal pharyngitis. | 1987 | Am Fam Physician | pmid:3105301 |
Robinson M | Prokinetic therapy for gastroesophageal reflux disease. | 1995 | Am Fam Physician | pmid:7653432 |
Winkelman L | Recommended revision to endocarditis prophylaxis. | 1991 | Am Fam Physician | pmid:1950954 |
Syphilis--recommended treatment schedules, 1976. | 1976 | Am Fam Physician | pmid:961559 | |
Ackley AM | Legionnaires' disease: an update. | 1981 | Am Fam Physician | pmid:7020390 |
Culp ER | Ilosone update. | 1980 | Am Fam Physician | pmid:7377065 |
Ocular prophylaxis for gonococcal ophthalmia neonatorum: reaffirmation recommendation statement. | 2012 | Am Fam Physician | pmid:22335221 | |
Tan HH | Antibacterial therapy for acne: a guide to selection and use of systemic agents. | 2003 | Am J Clin Dermatol | pmid:12688836 |
Taylor GA and Shalita AR | Benzoyl peroxide-based combination therapies for acne vulgaris: a comparative review. | 2004 | Am J Clin Dermatol | pmid:15301572 |
Ferguson DL et al. | Lichenoid lymphocytic vasculitis with a high component of histiocytes. Histogenetic implications in a specified clinical setting. | 1989 | Am J Dermatopathol | pmid:2729528 |
Rosen RA | The use of antibiotics in the initial management of recent dog-bite wounds. | 1985 | Am J Emerg Med | pmid:3970747 |
Altieri M et al. | Antibiotic prophylaxis in intraoral wounds. | 1986 | Am J Emerg Med | pmid:3096345 |
Paris DG et al. | Torsades de pointes induced by erythromycin and terfenadine. | 1994 | Am J Emerg Med | pmid:7945604 |
Traub SJ et al. | Use of pharmaceutical promotility agents in the treatment of body packers. | 2003 | Am J Emerg Med | pmid:14574669 |
Parker DL et al. | Elevated International Normalized Ratio associated with concurrent use of ophthalmic erythromycin and warfarin. | 2010 | Am J Health Syst Pharm | pmid:20044367 |
Howard KB et al. | Azithromycin versus erythromycin for community-acquired pneumonia: a cost-minimization analysis. | 1999 | Am J Health Syst Pharm | pmid:10478989 |
Erythromycin resistance in Finland declines after reduction in macrolide use. | 1997 | Am J Health Syst Pharm | pmid:9359947 | |
Lestico MR and Smith AD | Stevens-Johnson syndrome following erythromycin administration. | 1995 | Am J Health Syst Pharm | pmid:8528839 |
Horn JR | Analysis of purported erythromycin-warfarin interaction. | 2010 | Am J Health Syst Pharm | pmid:20516463 |